Liberia Vaccine Industry Outlook 2024 - 2028

See how Liberia Vaccine performed compared to key markets.

Key Market Indicators

Liberian Vaccination Coverage for one-year-old children is projected to maintain a steady average, reaching 70% by 2028 from its current 68% in 2023. This stability comes after a decline in the market, which saw a drop of three percentage points annually since 2005. Additionally, vaccination coverage for one-year-olds in Liberia is expected to rise slightly, hitting 80% by 2028 from 79% in 2023. This increment represents an average annual growth of 0.3 percentage points. Since 2004, however, the market has experienced a yearly decrease of 1.2 percentage points.

Liberia Vaccine Market Data and Forecasts

How much will Liberia Vaccine Market grow to 2028?

Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Liberia
Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Liberia
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Liberia
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Liberia
Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in Liberia

Other Top Countries about Vaccine